Paul Robert Hansen

Kort præsentation

Paul Robert Hansen earned his MS degree in Chemistry from the University of Copenhagen, Denmark in 1990. He was then a Reseasearch Assistant at the Department of Chemistry, Royal Veterinary and Agricultural University (KVL) for two years.
From 1993-1994, he was a visiting Ph.D.-student at the Department of Chemistry, University of Minnesota.
In 1996, he earned his Ph.D.-degree from the Department of Chemistry, Faculty of Life Sciences, University of Copenhagen, (formerly KVL), focusing on "New strategies in the synthesis of 2-acetamido-alpha–D–2-deoxy-glucopyranose O-Glycopeptides, neoglycoconjugates and photoreactive peptides" 

In 1997, he joined the Department of Natural Sciences, Faculty of Life Sciences, University of Copenhagen, as an Assistant Professor of Bioorganic Chemistry. He became an Associate Professor in 2000. 
In February 2012, he joined the Natural Products Research Group, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences (previously Faculty of Pharmaceutical Sciences), University of Copenhagen.

His research interests include: Antimicrobial peptides and analogues, peptide/peptidomimetic libraries and peptides as probes in immunology and cancer. He has co-authored more than 80 publications in the field of peptide chemistry/bioorganic chemistry and supervised numerous Ph.D. and M.S. students. In 2003 he received the Dana Lim award and in 2007 the Faculty of Life Sciences Teacher of the year award. He is the editor of the book Methods in Molecular Biology: Antimicrobial Peptides publised in 2017.

Research Projects and Major Research Collaborators

He is a partner in FP7-PEOPLE-2011-ITN TRAIN-ASAP (“Training Research AImed at Novel Antibacterial Strategies in Animals and People”) an interdisciplinary collaboration between 7 research groups from various institutions and Pfizer. This ITN is coordinated by Professor Luca Guardabassi, University of Copenhagen. 
He is also a member of the DANCARD (Danish Centre for Antibiotic Research and Development) consortium an interdisciplinary collaboration between 11 research groups from various institutions and companies, funded by a grant from the Danish Council for Strategic Research. This centre is coordinated by Professor Niels Frimodt-Møller (Hvidovre Hospital) and other collaborators include Associate Professor Reinhard Wimmer Aalborg University, Professor Anders-Løbner Olesen Roskilde University and Dr. Peter Damborg University of Copenhagen.
Furthermore, he is part of the EPI-Expose therapeutic vaccine platform project, which is a collaboration between Professor Peter Andersen (Project leader), Dr. Else-Marie Agger SSI, Dr. Per thor Straten (Herlev Hospital), Professor Jens Bukh (Hvidovre Hospital). The Project is funded by The Danish National Advanced Technology Foundation.
The project "epitope mapping of antibodies related to autoimmune diseases" is carried out in collaboration with Professor Gunnar Houen (SSI/Southern University of Denmark) 
In collaboration with Professor Andreas Kjær and his group (Dept. of Nuclear Medicine, Copenhagen University Hospital) they aim to develop peptide-based PET-ligands for the cancer specific receptor EGFRvIII.

Links:
http://www.train-asap.eu/ 
http://www.dancardproject.dk/ 
http://hoejteknologifonden.dk/en/project_gallery/project_gallery/vaccine_against_chronic_diseases/